Morgan Stanley’s Chembio diagnostics, Inc. CEMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,497
| Closed | -$662 | – | 7854 |
|
|
2023
Q1 | $662 | Sell |
1,497
-3,190
| -68% | -$1.25K | ﹤0.01% | 7403 |
|
|
2022
Q4 | $1.03K | Sell |
4,687
-1,552
| -25% | -$464 | ﹤0.01% | 7465 |
|
|
2022
Q3 | $2K | Sell |
6,239
-647
| -9% | -$441 | ﹤0.01% | 7526 |
|
|
2022
Q2 | $5K | Sell |
6,886
-4,916
| -42% | -$3.27K | ﹤0.01% | 7435 |
|
|
2022
Q1 | $9K | Sell |
11,802
-7,299
| -38% | -$6.81K | ﹤0.01% | 7456 |
|
|
2021
Q4 | $21K | Sell |
19,101
-103,022
| -84% | -$210K | ﹤0.01% | 7212 |
|
|
2021
Q3 | $305K | Buy |
122,123
+85,756
| +236% | +$238K | ﹤0.01% | 5773 |
|
|
2021
Q2 | $107K | Sell |
36,367
-21,346
| -37% | -$74.4K | ﹤0.01% | 6328 |
|
|
2021
Q1 | $202K | Sell |
57,713
-5,658
| -9% | -$31.5K | ﹤0.01% | 5655 |
|
|
2020
Q4 | $301K | Buy |
63,371
+16,352
| +35% | +$84.4K | ﹤0.01% | 5373 |
|
|
2020
Q3 | $229K | Buy |
47,019
+1,572
| +3% | +$7.45K | ﹤0.01% | 5034 |
|
|
2020
Q2 | $148K | Sell |
45,447
-7,378
| -14% | -$70.1K | ﹤0.01% | 5219 |
|
|
2020
Q1 | $270K | Buy |
52,825
+3,700
| +8% | +$15K | ﹤0.01% | 4738 |
|
|
2019
Q4 | $224K | Buy |
49,125
+4,400
| +10% | +$21.4K | ﹤0.01% | 5366 |
|
|
2019
Q3 | $274K | Buy |
44,725
+2,200
| +5% | +$13.1K | ﹤0.01% | 4976 |
|
|
2019
Q2 | $259K | Buy |
42,525
+6,305
| +17% | +$42.5K | ﹤0.01% | 4917 |
|
|
2019
Q1 | $201K | Buy |
36,220
+1,446
| +4% | +$9.39K | ﹤0.01% | 5064 |
|
|
2018
Q4 | $197K | Buy |
34,774
+16,274
| +88% | +$120K | ﹤0.01% | 5293 |
|
|
2018
Q3 | $194K | Buy |
18,500
+678
| +4% | +$7.28K | ﹤0.01% | 5467 |
|
|
2018
Q2 | $198K | Buy |
17,822
+354
| +2% | +$3.19K | ﹤0.01% | 5539 |
|
|
2018
Q1 | $140K | Sell |
17,468
-275
| -2% | -$2.2K | ﹤0.01% | 5614 |
|
|
2017
Q4 | $145K | Buy |
17,743
+718
| +4% | +$4.86K | ﹤0.01% | 5522 |
|
|
2017
Q3 | $106K | Hold |
17,025
| – | – | ﹤0.01% | 5561 |
|
|
2017
Q2 | $103K | Hold |
17,025
| – | – | ﹤0.01% | 5626 |
|
|
2017
Q1 | $90K | Buy |
17,025
+2,000
| +13% | +$11.7K | ﹤0.01% | 5640 |
|
|
2016
Q4 | $102K | Hold |
15,025
| – | – | ﹤0.01% | 5564 |
|
|
2016
Q3 | $111K | Buy |
15,025
+572
| +4% | +$4.12K | ﹤0.01% | 5263 |
|
|
2016
Q2 | $119K | Buy |
14,453
+2,653
| +22% | +$20.7K | ﹤0.01% | 5176 |
|
|
2016
Q1 | $71K | Buy |
11,800
+1,000
| +9% | +$5.16K | ﹤0.01% | 5472 |
|
|
2015
Q4 | $58K | Buy |
10,800
+4,800
| +80% | +$24.1K | ﹤0.01% | 5656 |
|
|
2015
Q3 | $24K | Buy |
6,000
+5,983
| +35,194% | +$27.1K | ﹤0.01% | 5998 |
|
|
2015
Q2 | $0 | Sell |
17
-74
| -81% | -$342 | ﹤0.01% | 7018 |
|
|
2015
Q1 | $0 | Sell |
91
-1,500
| -94% | -$5.9K | ﹤0.01% | 6959 |
|
|
2014
Q4 | $6K | Buy |
1,591
+325
| +26% | +$1.34K | ﹤0.01% | 6321 |
|
|
2014
Q3 | $5K | Hold |
1,266
| – | – | ﹤0.01% | 6354 |
|
|
2014
Q2 | $4K | Hold |
1,266
| – | – | ﹤0.01% | 6334 |
|
|
2014
Q1 | $4K | Sell |
1,266
-84
| -6% | -$295 | ﹤0.01% | 6295 |
|
|
2013
Q4 | $5K | Buy |
+1,350
| New | +$4.77K | ﹤0.01% | 6175 |
|
Other funds holding CEMI
Morgan Stanley's CEMI Position: Q2 2023 in Review
Morgan Stanley sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 1,497 shares — an estimated $662 sold.
Morgan Stanley first reported a position in CEMI in Q4 2013 and held it in 38 quarters. The position peaked at $305K in Q3 2021. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.
- Morgan Stanley reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
- Morgan Stanley sold 1,497 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $662.
- Morgan Stanley first reported a position in Chembio diagnostics, Inc. in Q4 2013 and held it in 38 quarters.
- Morgan Stanley's Chembio diagnostics, Inc. position peaked at $305K in Q3 2021.
- 1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.
Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.